Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Recce Pharmaceuticals Ltd. ( (AU:RCE) ) just unveiled an update.
Recce Pharmaceuticals Ltd. announced a $5 million placement to an Australian private investor and a pro-rata non-renounceable entitlement offer to raise approximately $10.8 million. The capital raising initiatives are expected to affect shareholder control dynamics, with potential dilution for existing shareholders due to the placement and entitlement offer.
More about Recce Pharmaceuticals Ltd.
Recce Pharmaceuticals Ltd. operates in the pharmaceutical industry, focusing on the development of synthetic anti-infectives. The company is known for its innovative approach to addressing antibiotic resistance and infections.
YTD Price Performance: -28.12%
Average Trading Volume: 184,492
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$76.52M
For a thorough assessment of RCE stock, go to TipRanks’ Stock Analysis page.